from the speedily evolving industry of cancer therapeutics, knowing the intricate mechanisms of Antibody-Drug Conjugates (ADCs) is important for creating effective treatment options. One of the more promising approaches is using in vitro bystander result assays, which Engage in a pivotal part in improving therapeutic efficacy. These assays, provide